NO964268L - Antiadhesive piperidin- og pyrrolidin-karboksylsyrer - Google Patents

Antiadhesive piperidin- og pyrrolidin-karboksylsyrer

Info

Publication number
NO964268L
NO964268L NO964268A NO964268A NO964268L NO 964268 L NO964268 L NO 964268L NO 964268 A NO964268 A NO 964268A NO 964268 A NO964268 A NO 964268A NO 964268 L NO964268 L NO 964268L
Authority
NO
Norway
Prior art keywords
piperidine
antiadhesive
carboxylic acids
pyrrolidine carboxylic
ring
Prior art date
Application number
NO964268A
Other languages
English (en)
Norwegian (no)
Other versions
NO964268D0 (no
Inventor
Alexander Toepfer
Gerhard Kretzschmar
Bernward Schoelkens
Peter Klemm
Christoph Huels
Dirk Seiffge
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO964268D0 publication Critical patent/NO964268D0/no
Publication of NO964268L publication Critical patent/NO964268L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/207Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO964268A 1995-10-09 1996-10-08 Antiadhesive piperidin- og pyrrolidin-karboksylsyrer NO964268L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19537334A DE19537334A1 (de) 1995-10-09 1995-10-09 Antiadhäsive Piperidin- und Pyrrolidin-Carbonsäuren

Publications (2)

Publication Number Publication Date
NO964268D0 NO964268D0 (no) 1996-10-08
NO964268L true NO964268L (no) 1997-04-10

Family

ID=7774241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964268A NO964268L (no) 1995-10-09 1996-10-08 Antiadhesive piperidin- og pyrrolidin-karboksylsyrer

Country Status (20)

Country Link
US (1) US5739300A (ja)
EP (1) EP0787739B1 (ja)
JP (1) JPH09110834A (ja)
KR (1) KR970021071A (ja)
CN (1) CN1150155A (ja)
AT (1) ATE231877T1 (ja)
AU (1) AU6799796A (ja)
BR (1) BR9605024A (ja)
CA (1) CA2187392A1 (ja)
CZ (1) CZ294096A3 (ja)
DE (2) DE19537334A1 (ja)
HR (1) HRP960459A2 (ja)
HU (1) HUP9602745A3 (ja)
MX (1) MX9604657A (ja)
NO (1) NO964268L (ja)
PL (1) PL316429A1 (ja)
SI (1) SI9600296A (ja)
SK (1) SK127796A3 (ja)
TR (1) TR199600799A2 (ja)
ZA (1) ZA968470B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1804299A (en) * 1997-12-08 1999-06-28 Glycomed Incorporated Sialyl lewis x and sialyl lewis a glycomimetics
US7060685B2 (en) * 2002-05-16 2006-06-13 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
AU2003237532B2 (en) 2002-06-12 2009-07-30 Symphony Evolution, Inc. Human ADAM-10 inhibitors
AU2003245595A1 (en) * 2002-07-03 2004-01-23 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
US7361644B2 (en) * 2003-11-19 2008-04-22 Glycomimetics, Inc. Specific antagonist for both E- and P-selectins
EP1685145A2 (en) * 2003-11-19 2006-08-02 GlycoMimetics, Inc. Glycomimetic antagonists for both e- and p-selectins
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
ES2375979T3 (es) * 2005-08-09 2012-03-07 Glycomimetics, Inc. Inhibidores glicomiméticos de la lectina pa-il, lectina pa-iil o ambas lectinas de pseudomonas.
JP5209476B2 (ja) * 2005-09-02 2013-06-12 グリコミメティクス, インコーポレイテッド ヘテロ二官能性全セレクチン阻害剤
US20090176717A1 (en) * 2006-06-01 2009-07-09 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
CA2666103C (en) 2006-10-12 2014-02-18 Glycomimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
EP2117561A1 (en) * 2007-02-09 2009-11-18 GlycoMimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
EP2318015B1 (en) * 2008-06-13 2013-08-07 GlycoMimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
WO2010126888A1 (en) * 2009-05-01 2010-11-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
DK2794626T6 (da) 2011-12-22 2020-08-24 Glycomimetics Inc E-selectin-antagonistforbindelser
ES2668045T3 (es) 2012-12-07 2018-05-16 Glycomimetics, Inc. Compuestos, composiciones y métodos que usan antagonistas de la E-selectina para la movilización de las células hematopoyéticas
HUE045542T2 (hu) 2014-12-03 2019-12-30 Glycomimetics Inc E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
US11045485B2 (en) 2016-01-22 2021-06-29 Glycomimetics, Inc. Glycomimetic inhibitors of PA-IL and PA-IIL lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
KR20240046288A (ko) 2016-10-07 2024-04-08 글리코미메틱스, 인크. 매우 강력한 다량체성 e-셀렉틴 길항물질
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス, インコーポレイテッド E-セレクチンアンタゴニストとしてのガラクトピラノシル-シクロヘキシル誘導体
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
KR20200104889A (ko) 2017-12-29 2020-09-04 글리코미메틱스, 인크. E-셀렉틴 및 갈렉틴-3의 이종이기능성 억제제
CA3091454A1 (en) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0671409A3 (de) * 1994-03-11 1996-06-12 Hoechst Ag Malonsäurederivate mit antiadhäsiven Eigenschaften.

Also Published As

Publication number Publication date
CN1150155A (zh) 1997-05-21
MX9604657A (es) 1998-04-30
DE59610093D1 (de) 2003-03-06
NO964268D0 (no) 1996-10-08
HU9602745D0 (en) 1996-11-28
BR9605024A (pt) 1998-06-30
EP0787739A1 (de) 1997-08-06
SI9600296A (en) 1997-04-30
KR970021071A (ko) 1997-05-28
SK127796A3 (en) 1997-05-07
CA2187392A1 (en) 1997-04-10
HUP9602745A2 (en) 1997-05-28
ZA968470B (en) 1997-04-09
EP0787739B1 (de) 2003-01-29
HUP9602745A3 (en) 1998-03-02
CZ294096A3 (en) 1997-04-16
PL316429A1 (en) 1997-04-14
AU6799796A (en) 1997-04-17
HRP960459A2 (en) 1998-02-28
US5739300A (en) 1998-04-14
TR199600799A2 (tr) 1997-04-22
ATE231877T1 (de) 2003-02-15
JPH09110834A (ja) 1997-04-28
DE19537334A1 (de) 1997-04-10

Similar Documents

Publication Publication Date Title
NO964268L (no) Antiadhesive piperidin- og pyrrolidin-karboksylsyrer
DE68917881D1 (de) Ansteuerungssignalerzeuger für in Halbbrückenanordnung verbundene Transistoren.
CA2218458A1 (en) Method and apparatus for design verification using emulation and simulation
NO891988L (no) Anordning og fremgangsmaate for maaling eller inngrep i en broenn, samt anvendelse av anordningen.
DE68908337D1 (de) Drehmomentmessfuehler.
ID16329A (id) Metode untuk membuka cetakan puputan yang terbuka pada bagian ujung bawah dengan pencetakan secara suntikan
DE68911975D1 (de) Ophthalmoskopisches Diagnoseverfahren und Gerät.
DE69021116D1 (de) Logikleistungsprüfung und Übergangsfehlererkennung.
DE68905755D1 (de) Drehmomentmessfuehler.
DE69015565D1 (de) Ultraschallprüfvorrichtung.
DK137690A (da) Pyrimidinyl-substituerede hydroxysyrer, lactoner og estere
DE3875350D1 (de) Reifengleichfoermigkeitspruefungsmaschine und verfahren dazu.
DE3887053D1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
FR2704068B1 (fr) Chapelet de sondes perfectionne.
DE68910134D1 (de) Homogener enzymimmuntest.
FI963638A0 (fi) Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi
DE68922846D1 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren.
NO975600D0 (no) Tidlig diagnostisk test
DE68922047D1 (de) Formbare Styrol-Maleinsäureanhydridcopolymer/Polybutylenterephthalatzusammensetzung.
DE59706367D1 (de) Überwachungsorgan mit Prüfstrahl im Zusammenhang mit Verpackungsmaschinen
NO913568D0 (no) Hydraulisk aktivisert broennventil, samt fremgangsmaate fortesting av formasjoner.
WO2001006250A3 (en) Thermo-chemical sensors and uses thereof
NO972046D0 (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
DE58908708D1 (de) Anschlusseinheit zum Anschliessen und Verbinden von elektrischen Leitungen.
DE68916834D1 (de) Electronic cash register with memory defect judging means.